Connect your AI

ResMed RMD Total Non-Current Liabilities

Total Non-Current Liabilities at other companies

Eli LillyLLY

$48.74B+12.1%

Viemed Healthcare, Inc.VMD

$10.86M+85.8%

Tactile Systems TechnologyTCMD

$18.24M-53.5%

Other financials

Income statement

Revenue$1.4B+10.8%

Gross profit$891.0M+16.3%

Operating income$499.8M+17.3%

Net income$398.7M+9.2%

EPS (diluted)$2.74+10.5%

Balance sheet

Cash & equivalents$1.7B+78.0%

Total debt$1.1B+29.8%

Total equity$6.5B+17.1%

Total assets$8.8B+16.1%

Cash flow

Operating cash flow$554.1M-4.2%

CapEx$33.7M+61.8%

Free cash flow$520.5M-6.7%

Valuation

Market cap$30.31B-23.6%

Enterprise value$29.75B-24.3%

P/E20×-8.4×

P/S5.5×-2.2×

Profitability

Gross margin61.6%+2.8pp

Operating margin34.2%+2.1pp

Net margin27.4%+1.3pp

FCF margin31.7%+0.4pp

Returns & leverage

Return on equity25.2%-0.6pp

Debt / equity0.2×0.0×

Current ratio3×-0.4×

Where this comes from

Reported directly by ResMed in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesNoncurrent.

The official record: ResMed’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about ResMed's total non-current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is ResMed's total non-current liabilities?: ResMed (RMD) reported total non-current liabilities of $941.16M in Q1 2026.
How has ResMed's total non-current liabilities changed year-over-year?: ResMed's total non-current liabilities decreased by 12.9% year-over-year, from $1.08B to $941.16M.
What is the long-term trend for ResMed's total non-current liabilities?: Over 4 years (2021 to 2025), ResMed's total non-current liabilities has grown at a 6.3% compound annual growth rate (CAGR), from $930.68M to $1.19B.
What does total non-current liabilities mean?: The sum of all long-term obligations due beyond one year — long-term debt, lease liabilities, pension obligations, and deferred items.